SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain
Qianhui Yi, Xiaojun Han, Henry Yu, Huei-Yu Chen, Dinghong Qiu, Jie Su, Rongtuan Lin, Gerald Batist, Jian Wu
Topics & Concepts
Androgen receptorProstate cancerCancer researchAntiandrogensAndrogenBiologyAndrogen deprivation therapyApoptosisInternal medicineEndocrinologyCancerMedicineHormoneBiochemistryGeneticsProstate Cancer Treatment and ResearchCancer, Lipids, and MetabolismProtein Degradation and Inhibitors